Prostate Cancer Treatment Guideline

Updated NCCN Guidelines for Prostate Cancer Provide Comprehensive Guidance

New Recommendations for Diagnosis, Risk Stratification, and Treatment

The National Comprehensive Cancer Network (NCCN) has released updated guidelines for the diagnosis, risk stratification, and treatment of prostate cancer. The NCCN Guidelines for Prostate Cancer are a widely respected and comprehensive resource for healthcare professionals who care for patients with this disease.

Key Updates in Version 3.2019

The most recent version of the guidelines (Version 3.2019) includes several important updates from the previous version (Version 2.2019):

1. PROS-14: Recommendations on systemic therapy for castration-naive metastatic prostate cancer
2. Updated risk stratification criteria: New criteria for determining the appropriate treatment approach based on the patient's risk of recurrence
3. Expanded treatment options: Additional treatment options for patients with localized and advanced prostate cancer

Importance for Healthcare Professionals

The updated NCCN Guidelines for Prostate Cancer provide healthcare professionals with the most current and evidence-based recommendations for the diagnosis, risk stratification, and treatment of this disease. By following these guidelines, healthcare professionals can help to ensure that their patients receive the best possible care.

Impact on Patients

The NCCN Guidelines for Prostate Cancer can help patients to understand their disease and make informed decisions about their treatment options. By working with their healthcare team, patients can use the guidelines to develop a personalized treatment plan that meets their individual needs.